qi-019a
qi-019a: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Lead developer: WORK Medical Technology Group LTD (WOK)
Development Pipeline (1)
| Company | Phase |
|---|---|
| WORK Medical Technology Group LTD (WOK) | Early Phase 1 |
Clinical Trials (1)
A Clinical Study to Evaluate the Safety and Preliminary Efficacy of QI-019A in Patients With Relapsed/Refractory Multiple Myeloma.
Frequently asked questions
Who is developing qi-019a?
qi-019a is being developed by WORK Medical Technology Group LTD.
How many clinical trials involve qi-019a?
BioSniper tracks 1 clinical trial involving qi-019a.
Analyze WORK Medical Technology Group LTD & qi-019a with AI
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
- 200 free AI credits / month to run live multi-agent analysis
- Watchlist, catalyst alerts & the biotech event calendar
- Full pipeline, financials & FDA data on every company